Bourne Partners is an international healthcare focused financial advisory firm. Unlike generalist firms, we concentrate on providing world-class service and capital to middle-market healthcare companies around the globe. Specifically, we offer a complete range of financial advisory services to companies in the specialty pharmaceutical, medical device, biotechnology and service segments of the healthcare arena. We have advised the senior management team of clients from a broad range of companies and have significant transactional and operating experience. Our partners are also active in the direct management of portfolio companies where we can leverage our unique understanding and expertise.
- Specialty Pharmaceutical Industry Trading Multiple Analysis
- An Overview of Global Regulatory Trends in the Nutraceutical Industry – April 2013
- Biosimilars: Opportunity Amongst Uncertainty
- Modernizing Pharma Markets in Brazil and Mexico
- The Medical Device Excise Tax (MDET) – Ramifications for Device Makers